Opiant Pharmaceuticals financials at a glance
| Year | Year | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2008 | 2022 | 2023 | 2006 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $28.23M | $13.98M | $40.52M | $29.63M | $47.79M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 66.89% | -69.47% | 58.54% | 47.89% | 45.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 13.11% | -151.55% | 26.93% | -7.56% | 10.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | $0.00 | $0.00 | |||||||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
1.58m | 0.62m | 0.92m | 1.31m | 1.76m | 1.82m | 1.89m | 2.04m | 2.07m | 3.83m | 4.09m | 4.26m | 4.72m | 0m | 4.72m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-9.22M | $-0.52M | $4.06M | $-2.03M | $1.93M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $3.76M | $-2.08M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-4.44 | $-0.18 | $0.94 | $-0.49 | $0.43 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |